Merck Ventures
BV, Amsterdam, The Netherlands, a subsidiary of Merck KGaA, Darmstadt, Germany
“Our investments will be aligned with the strategic interests of Merck KGaA, Darmstadt, Germany, though formally separated by a ‘Chinese Wall’. With our infrastructure of a leading science technology company we provide start-ups with the support they need to make their vision a commercial success.”
Roel Bulthuis
Senior Vice President and Managing Director of Merck Ventures BV, Amsterdam, The Netherlands, a subsidiary of Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, Expands its Corporate Ventures Fund
Darmstadt, Germany, June 8, 2016 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced an increased commitment to its Corporate Ventures fund under the new Corporate Ventures fund roof (official name: Merck Ventures BV, Amsterdam, The Netherlands, a subsidiary of Merck KGaA, Darmstadt, Germany). Four dedicated investment teams will focus on Healthcare, Life Science, Performance Materials and new businesses. The total volume of the newly set-up Corporate Ventures fund of Merck KGaA, Darmstadt, Germany, can reach up to € 300 million once fully invested, doubling the volume of the previous biopharma venture fund of € 150 million.
moreUpcoming Events
2017/10/03
SynBioBeta San Francisco 2017
Andreas Jurgeit, Ivestment Director and Clemens Lakner, Associate of the Life Science team will be speaking at SynbioBeta in San Francisco.
